QQ客服 官方微博 反馈留言

	Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer"s disease: A phase II multicenter randomized controlled trial
	Xiao S., Wang T., Li X., Zhao Z., Liu X., Wang X., Xie H., Sun L., Jiang Q., Luo B., Shang L., Chen W., Bai Y., Tang M., He M., Liu K., Ma Q., Song Z., Qin Y., Ma X., He J.
刊名	Alzheimer"s and Dementia
	2015
卷号	11
ISSN号	1552-5260
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3543226
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Xiao S., Wang T., Li X., Zhao Z., Liu X., Wang X., Xie H., Sun L., Jiang Q., Luo B., Shang L., Chen W., Bai Y., Tang M., He M., Liu K., Ma Q., Song Z., Qin Y., Ma X., He J.. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer"s disease: A phase II multicenter randomized controlled trial[J]. Alzheimer"s and Dementia,2015,11.
APA	Xiao S., Wang T., Li X., Zhao Z., Liu X., Wang X., Xie H., Sun L., Jiang Q., Luo B., Shang L., Chen W., Bai Y., Tang M., He M., Liu K., Ma Q., Song Z., Qin Y., Ma X., He J..(2015).Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer"s disease: A phase II multicenter randomized controlled trial.Alzheimer"s and Dementia,11.
MLA	Xiao S., Wang T., Li X., Zhao Z., Liu X., Wang X., Xie H., Sun L., Jiang Q., Luo B., Shang L., Chen W., Bai Y., Tang M., He M., Liu K., Ma Q., Song Z., Qin Y., Ma X., He J.."Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer"s disease: A phase II multicenter randomized controlled trial".Alzheimer"s and Dementia 11(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。